{"transactions":[{"id":4624133,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-09-18T20:43:16.000Z","date":"2026-09-16","kind":"exercise","planned":false,"acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":37500,"derivative":{"underlying":"Class A Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001689575-26-000032","document":"form4-09182026_080912.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000032/form4-09182026_080912.xml","form_type":"4"}},{"id":4624132,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:43:16.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":3039,"price":98.995,"value":300845.805,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.60 to $99.305 per share, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 115,476 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 280,228 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":115476,"source":{"system":"sec-edgar","filing":"0001689575-26-000032","document":"form4-09182026_080912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000032/form4-09182026_080912.xml","form_type":"4"}},{"id":4624131,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:43:16.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":4141,"price":98.27,"value":406936.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.565 to $98.535 per share, inclusive."}],"balance_after":118515,"source":{"system":"sec-edgar","filing":"0001689575-26-000032","document":"form4-09182026_080912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000032/form4-09182026_080912.xml","form_type":"4"}},{"id":4624130,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:43:16.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":1525,"price":96.9009,"value":147773.8725,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.445 to $97.40 per share, inclusive."}],"balance_after":122656,"source":{"system":"sec-edgar","filing":"0001689575-26-000032","document":"form4-09182026_080912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000032/form4-09182026_080912.xml","form_type":"4"}},{"id":4624129,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:43:16.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":148,"price":95.405,"value":14119.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.29 to $95.52 per share, inclusive."}],"balance_after":124181,"source":{"system":"sec-edgar","filing":"0001689575-26-000032","document":"form4-09182026_080912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000032/form4-09182026_080912.xml","form_type":"4"}},{"id":4624128,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:43:16.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":1648,"price":94.258,"value":155337.184,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.23 to $94.855 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 through 7 of this Form 4."}],"balance_after":124329,"source":{"system":"sec-edgar","filing":"0001689575-26-000032","document":"form4-09182026_080912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000032/form4-09182026_080912.xml","form_type":"4"}},{"id":4624127,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:43:16.000Z","date":"2026-09-16","kind":"exercise","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":125977,"source":{"system":"sec-edgar","filing":"0001689575-26-000032","document":"form4-09182026_080912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000032/form4-09182026_080912.xml","form_type":"4"}},{"id":4624107,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-09-18T20:39:13.000Z","date":"2026-09-16","kind":"exercise","planned":false,"acquired":false,"shares":7197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":14393,"derivative":{"underlying":"Class A Common Stock","underlying_shares":7197},"source":{"system":"sec-edgar","filing":"0001944119-26-000037","document":"form4-09182026_080909.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000037/form4-09182026_080909.xml","form_type":"4"}},{"id":4624106,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:39:13.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":1079,"price":98.995,"value":106815.605,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.60 to $99.305 per share, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 44,945 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 71,667 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":44945,"source":{"system":"sec-edgar","filing":"0001944119-26-000037","document":"form4-09182026_080909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000037/form4-09182026_080909.xml","form_type":"4"}},{"id":4624105,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:39:13.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":1470,"price":98.27,"value":144456.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.565 to $98.535 per share, inclusive."}],"balance_after":46024,"source":{"system":"sec-edgar","filing":"0001944119-26-000037","document":"form4-09182026_080909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000037/form4-09182026_080909.xml","form_type":"4"}},{"id":4624104,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:39:13.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":541,"price":96.9009,"value":52423.3869,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.445 to $97.40 per share, inclusive."}],"balance_after":47494,"source":{"system":"sec-edgar","filing":"0001944119-26-000037","document":"form4-09182026_080909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000037/form4-09182026_080909.xml","form_type":"4"}},{"id":4624103,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:39:13.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":52,"price":95.405,"value":4961.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.29 to $95.52 per share, inclusive."}],"balance_after":48035,"source":{"system":"sec-edgar","filing":"0001944119-26-000037","document":"form4-09182026_080909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000037/form4-09182026_080909.xml","form_type":"4"}},{"id":4624102,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:39:13.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":586,"price":94.258,"value":55235.188,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.23 to $94.855 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 through 7 of this Form 4."}],"balance_after":48087,"source":{"system":"sec-edgar","filing":"0001944119-26-000037","document":"form4-09182026_080909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000037/form4-09182026_080909.xml","form_type":"4"}},{"id":4624101,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:39:13.000Z","date":"2026-09-16","kind":"exercise","planned":false,"acquired":true,"shares":7197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":48673,"source":{"system":"sec-edgar","filing":"0001944119-26-000037","document":"form4-09182026_080909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000037/form4-09182026_080909.xml","form_type":"4"}},{"id":4624140,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36005,"kind":"person","name":"Fuchs Thomas","position":1,"cik":"0002083937","reported_name":"Fuchs Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-09-18T20:37:31.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":false,"shares":1146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall vest in three equal installments on September 17, 2026, September 17, 2027, and September 17, 2028, subject to the reporting person's continued service to the Issuer on the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award shall vest in three equal installments on September 17, 2026, September 17, 2027, and September 17, 2028, subject to the reporting person's continued service to the Issuer on the applicable vesting date."}],"balance_after":2292,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1146},"source":{"system":"sec-edgar","filing":"0002083937-26-000005","document":"form4-09182026_080926.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000208393726000005/form4-09182026_080926.xml","form_type":"4"}},{"id":4624139,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36005,"kind":"person","name":"Fuchs Thomas","position":1,"cik":"0002083937","reported_name":"Fuchs Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:37:31.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":true,"shares":1146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":1146,"source":{"system":"sec-edgar","filing":"0002083937-26-000005","document":"form4-09182026_080926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000208393726000005/form4-09182026_080926.xml","form_type":"4"}},{"id":4615857,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-09-11T20:13:35.000Z","date":"2026-09-09","kind":"exercise","planned":false,"acquired":false,"shares":6547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":6547,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6547},"source":{"system":"sec-edgar","filing":"0001689575-26-000030","document":"form4-09112026_080931.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000030/form4-09112026_080931.xml","form_type":"4"}},{"id":4615856,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-11T20:13:35.000Z","date":"2026-09-09","kind":"sale","planned":false,"acquired":false,"shares":3692,"price":84.2178,"value":310932.1176,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.07 to $84.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 107,227 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate of 298,978 shares of Class A Common Stock and options to purchase up to an aggregate of 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":107227,"source":{"system":"sec-edgar","filing":"0001689575-26-000030","document":"form4-09112026_080931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000030/form4-09112026_080931.xml","form_type":"4"}},{"id":4615855,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-11T20:13:35.000Z","date":"2026-09-09","kind":"exercise","planned":false,"acquired":true,"shares":6547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":110919,"source":{"system":"sec-edgar","filing":"0001689575-26-000030","document":"form4-09112026_080931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000030/form4-09112026_080931.xml","form_type":"4"}},{"id":4615845,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-09-11T20:10:55.000Z","date":"2026-09-09","kind":"exercise","planned":false,"acquired":false,"shares":2462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":2463,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2462},"source":{"system":"sec-edgar","filing":"0001944119-26-000035","document":"form4-09112026_080950.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000035/form4-09112026_080950.xml","form_type":"4"}},{"id":4615844,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-11T20:10:55.000Z","date":"2026-09-09","kind":"sale","planned":false,"acquired":false,"shares":1285,"price":84.2179,"value":108220.0015,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.08 to $84.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 41,476 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate of 78,864 shares of Class A Common Stock and options to purchase up to an aggregate of 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":41476,"source":{"system":"sec-edgar","filing":"0001944119-26-000035","document":"form4-09112026_080950.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000035/form4-09112026_080950.xml","form_type":"4"}},{"id":4615843,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-11T20:10:55.000Z","date":"2026-09-09","kind":"exercise","planned":false,"acquired":true,"shares":2462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":42761,"source":{"system":"sec-edgar","filing":"0001944119-26-000035","document":"form4-09112026_080950.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000035/form4-09112026_080950.xml","form_type":"4"}},{"id":2075,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-09-03T20:09:28.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on December 1, 2022, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on December 1, 2022, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":717},"source":{"system":"sec-edgar","filing":"0001944119-26-000033","document":"form4-09032026_080923.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000033/form4-09032026_080923.xml","form_type":"4"}},{"id":2074,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-03T20:09:28.000Z","date":"2026-09-01","kind":"sale","planned":false,"acquired":false,"shares":372,"price":83.839,"value":31188.108,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.71 to $83.84 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 40,299 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 81,326 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":40299,"source":{"system":"sec-edgar","filing":"0001944119-26-000033","document":"form4-09032026_080923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000033/form4-09032026_080923.xml","form_type":"4"}},{"id":2073,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-03T20:09:28.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":40671,"source":{"system":"sec-edgar","filing":"0001944119-26-000033","document":"form4-09032026_080923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000033/form4-09032026_080923.xml","form_type":"4"}},{"id":721342,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":34029,"kind":"person","name":"GARDNER MARK A","position":1,"cik":"0001955242","reported_name":"GARDNER MARK A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Unit","published_at":"2026-07-01T20:10:46.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":35441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall vest as to 25% of the total award annually each July 1, with the first tranche vesting on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date.  These restricted stock units do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award shall vest as to 25% of the total award annually each July 1, with the first tranche vesting on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date.  These restricted stock units do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":35441,"derivative":{"underlying":"Class A Common Stock","underlying_shares":35441},"source":{"system":"sec-edgar","filing":"0001955242-26-000011","document":"form4-07012026_080742.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000195524226000011/form4-07012026_080742.xml","form_type":"4"}},{"id":729232,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-06-23T20:31:21.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":false,"shares":3576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The entire award vested or vests on the earlier of the: (i) date of the 2026 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The entire award vested or vests on the earlier of the: (i) date of the 2026 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3576},"source":{"system":"sec-edgar","filing":"0001585017-26-000002","document":"form4-06232026_080617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000158501726000002/form4-06232026_080617.xml","form_type":"4"}},{"id":729231,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36008,"kind":"person","name":"Ryan Jason","position":1,"cik":"0001585017","reported_name":"Ryan Jason","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-23T20:31:21.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":true,"shares":3576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":15480,"source":{"system":"sec-edgar","filing":"0001585017-26-000002","document":"form4-06232026_080617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000158501726000002/form4-06232026_080617.xml","form_type":"4"}},{"id":729636,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36121,"kind":"person","name":"RUCH JOSHUA","position":1,"cik":"0000943431","reported_name":"RUCH JOSHUA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-06-23T20:30:25.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":false,"shares":3576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The entire award vested or vests on the earlier of the: (i) date of the 2026 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The entire award vested or vests on the earlier of the: (i) date of the 2026 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3576},"source":{"system":"sec-edgar","filing":"0000943431-26-000002","document":"form4-06232026_080617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/943431/000094343126000002/form4-06232026_080617.xml","form_type":"4"}},{"id":729635,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36121,"kind":"person","name":"RUCH JOSHUA","position":1,"cik":"0000943431","reported_name":"RUCH JOSHUA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-06-23T20:30:25.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":4248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The entire award shall vest on the earlier of the (i) date of the 2027 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The entire award shall vest on the earlier of the (i) date of the 2027 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":4248,"derivative":{"underlying":"Class A Common Stock","underlying_shares":4248},"source":{"system":"sec-edgar","filing":"0000943431-26-000002","document":"form4-06232026_080617.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/943431/000094343126000002/form4-06232026_080617.xml","form_type":"4"}},{"id":729634,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36121,"kind":"person","name":"RUCH JOSHUA","position":1,"cik":"0000943431","reported_name":"RUCH JOSHUA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-23T20:30:25.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":true,"shares":3576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":33299,"source":{"system":"sec-edgar","filing":"0000943431-26-000002","document":"form4-06232026_080617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/943431/000094343126000002/form4-06232026_080617.xml","form_type":"4"}},{"id":729227,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36007,"kind":"person","name":"PFENNIGER RICHARD C JR","position":1,"cik":"0001200796","reported_name":"PFENNIGER RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-06-23T20:29:24.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":false,"shares":3576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The entire award vested or vests on the earlier of the: (i) date of the 2026 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The entire award vested or vests on the earlier of the: (i) date of the 2026 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3576},"source":{"system":"sec-edgar","filing":"0001200796-26-000002","document":"form4-06232026_080619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120079626000002/form4-06232026_080619.xml","form_type":"4"}},{"id":729226,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36007,"kind":"person","name":"PFENNIGER RICHARD C JR","position":1,"cik":"0001200796","reported_name":"PFENNIGER RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-06-23T20:29:24.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":4248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The entire award shall vest on the earlier of the (i) date of the 2027 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The entire award shall vest on the earlier of the (i) date of the 2027 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":4248,"derivative":{"underlying":"Class A Common Stock","underlying_shares":4248},"source":{"system":"sec-edgar","filing":"0001200796-26-000002","document":"form4-06232026_080619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120079626000002/form4-06232026_080619.xml","form_type":"4"}},{"id":729225,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36007,"kind":"person","name":"PFENNIGER RICHARD C JR","position":1,"cik":"0001200796","reported_name":"PFENNIGER RICHARD C JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-23T20:29:24.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":true,"shares":3576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":45082,"source":{"system":"sec-edgar","filing":"0001200796-26-000002","document":"form4-06232026_080619.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000120079626000002/form4-06232026_080619.xml","form_type":"4"}},{"id":729230,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":10282,"kind":"person","name":"Meister Keith A.","position":1,"cik":"0001307631","reported_name":"Meister Keith A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-06-23T20:28:25.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":false,"shares":3576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The entire award vested or vests on the earlier of the: (i) date of the 2026 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The entire award vested or vests on the earlier of the: (i) date of the 2026 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3576},"source":{"system":"sec-edgar","filing":"0001307631-26-000002","document":"form4-06232026_080621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000130763126000002/form4-06232026_080621.xml","form_type":"4"}},{"id":729229,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":10282,"kind":"person","name":"Meister Keith A.","position":1,"cik":"0001307631","reported_name":"Meister Keith A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-06-23T20:28:25.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":4248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The entire award shall vest on the earlier of the (i) date of the 2027 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The entire award shall vest on the earlier of the (i) date of the 2027 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":4248,"derivative":{"underlying":"Class A Common Stock","underlying_shares":4248},"source":{"system":"sec-edgar","filing":"0001307631-26-000002","document":"form4-06232026_080621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000130763126000002/form4-06232026_080621.xml","form_type":"4"}},{"id":729228,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":10282,"kind":"person","name":"Meister Keith A.","position":1,"cik":"0001307631","reported_name":"Meister Keith A.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-23T20:28:25.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":true,"shares":3576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":23705,"source":{"system":"sec-edgar","filing":"0001307631-26-000002","document":"form4-06232026_080621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000130763126000002/form4-06232026_080621.xml","form_type":"4"}},{"id":729224,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":19007,"kind":"person","name":"Leproust Emily M.","position":1,"cik":"0001753655","reported_name":"Leproust Emily M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-06-23T20:27:30.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":false,"shares":3576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The entire award vested or vests on the earlier of the: (i) date of the 2026 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The entire award vested or vests on the earlier of the: (i) date of the 2026 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3576},"source":{"system":"sec-edgar","filing":"0001753655-26-000002","document":"form4-06232026_080626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000175365526000002/form4-06232026_080626.xml","form_type":"4"}},{"id":729223,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":19007,"kind":"person","name":"Leproust Emily M.","position":1,"cik":"0001753655","reported_name":"Leproust Emily M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-06-23T20:27:30.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":4248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The entire award shall vest on the earlier of the (i) date of the 2027 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The entire award shall vest on the earlier of the (i) date of the 2027 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":4248,"derivative":{"underlying":"Class A Common Stock","underlying_shares":4248},"source":{"system":"sec-edgar","filing":"0001753655-26-000002","document":"form4-06232026_080626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000175365526000002/form4-06232026_080626.xml","form_type":"4"}},{"id":729222,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":19007,"kind":"person","name":"Leproust Emily M.","position":1,"cik":"0001753655","reported_name":"Leproust Emily M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-23T20:27:30.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":true,"shares":3576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":24852,"source":{"system":"sec-edgar","filing":"0001753655-26-000002","document":"form4-06232026_080626.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000175365526000002/form4-06232026_080626.xml","form_type":"4"}},{"id":729218,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36005,"kind":"person","name":"Fuchs Thomas","position":1,"cik":"0002083937","reported_name":"Fuchs Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-06-23T20:26:35.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":4248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The entire award shall vest on the earlier of the (i) date of the 2027 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The entire award shall vest on the earlier of the (i) date of the 2027 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":4248,"derivative":{"underlying":"Class A Common Stock","underlying_shares":4248},"source":{"system":"sec-edgar","filing":"0002083937-26-000003","document":"form4-06232026_080631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000208393726000003/form4-06232026_080631.xml","form_type":"4"}},{"id":729221,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36006,"kind":"person","name":"Casdin Eli","position":1,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-06-23T20:25:27.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":false,"shares":3576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The entire award vested or vests on the earlier of the: (i) date of the 2026 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The entire award vested or vests on the earlier of the: (i) date of the 2026 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3576},"source":{"system":"sec-edgar","filing":"0001534264-26-000002","document":"form4-06232026_080622.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000153426426000002/form4-06232026_080622.xml","form_type":"4"}},{"id":729220,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36006,"kind":"person","name":"Casdin Eli","position":1,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-06-23T20:25:27.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":4248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The entire award shall vest on the earlier of the (i) date of the 2027 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The entire award shall vest on the earlier of the (i) date of the 2027 annual meeting of the Issuer's stockholders, or (ii) first anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":4248,"derivative":{"underlying":"Class A Common Stock","underlying_shares":4248},"source":{"system":"sec-edgar","filing":"0001534264-26-000002","document":"form4-06232026_080622.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000153426426000002/form4-06232026_080622.xml","form_type":"4"}},{"id":729219,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36006,"kind":"person","name":"Casdin Eli","position":1,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-23T20:25:27.000Z","date":"2026-06-18","kind":"exercise","planned":false,"acquired":true,"shares":3576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":24093,"source":{"system":"sec-edgar","filing":"0001534264-26-000002","document":"form4-06232026_080622.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000153426426000002/form4-06232026_080622.xml","form_type":"4"}},{"id":732356,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-06-18T20:11:25.000Z","date":"2026-06-16","kind":"exercise","planned":false,"acquired":false,"shares":7197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":21590,"derivative":{"underlying":"Class A Common Stock","underlying_shares":7197},"source":{"system":"sec-edgar","filing":"0001944119-26-000031","document":"form4-06182026_080621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000031/form4-06182026_080621.xml","form_type":"4"}},{"id":732355,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-18T20:11:25.000Z","date":"2026-06-16","kind":"sale","planned":false,"acquired":false,"shares":863,"price":61.5035,"value":53077.5205,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.44 to $61.69 per share, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 39,954 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 82,043 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":39954,"source":{"system":"sec-edgar","filing":"0001944119-26-000031","document":"form4-06182026_080621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000031/form4-06182026_080621.xml","form_type":"4"}},{"id":732354,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-18T20:11:25.000Z","date":"2026-06-16","kind":"sale","planned":false,"acquired":false,"shares":2106,"price":60.8291,"value":128106.0846,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.40 to $61.35 per share, inclusive."}],"balance_after":40817,"source":{"system":"sec-edgar","filing":"0001944119-26-000031","document":"form4-06182026_080621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000031/form4-06182026_080621.xml","form_type":"4"}},{"id":732353,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-18T20:11:25.000Z","date":"2026-06-16","kind":"sale","planned":false,"acquired":false,"shares":760,"price":59.7543,"value":45413.268,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.26 to $60.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 and 5 of this Form 4."}],"balance_after":42923,"source":{"system":"sec-edgar","filing":"0001944119-26-000031","document":"form4-06182026_080621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000031/form4-06182026_080621.xml","form_type":"4"}},{"id":732352,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-18T20:11:25.000Z","date":"2026-06-16","kind":"exercise","planned":false,"acquired":true,"shares":7197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":43683,"source":{"system":"sec-edgar","filing":"0001944119-26-000031","document":"form4-06182026_080621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000031/form4-06182026_080621.xml","form_type":"4"}},{"id":732197,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-06-18T20:09:02.000Z","date":"2026-06-16","kind":"exercise","planned":false,"acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":56250,"derivative":{"underlying":"Class A Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001689575-26-000028","document":"form4-06182026_080658.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000028/form4-06182026_080658.xml","form_type":"4"}},{"id":732196,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-18T20:09:02.000Z","date":"2026-06-16","kind":"sale","planned":false,"acquired":false,"shares":2429,"price":61.5035,"value":149392.0015,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.44 to $61.69 per share, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 104,372 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 305,525 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":104372,"source":{"system":"sec-edgar","filing":"0001689575-26-000028","document":"form4-06182026_080658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000028/form4-06182026_080658.xml","form_type":"4"}},{"id":732195,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-18T20:09:02.000Z","date":"2026-06-16","kind":"sale","planned":false,"acquired":false,"shares":5932,"price":60.8291,"value":360838.2212,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.40 to $61.35 per share, inclusive."}],"balance_after":106801,"source":{"system":"sec-edgar","filing":"0001689575-26-000028","document":"form4-06182026_080658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000028/form4-06182026_080658.xml","form_type":"4"}},{"id":732194,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-18T20:09:02.000Z","date":"2026-06-16","kind":"sale","planned":false,"acquired":false,"shares":2140,"price":59.7543,"value":127874.202,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.26 to $60.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 and 5 of this Form 4."}],"balance_after":112733,"source":{"system":"sec-edgar","filing":"0001689575-26-000028","document":"form4-06182026_080658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000028/form4-06182026_080658.xml","form_type":"4"}},{"id":732193,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-18T20:09:02.000Z","date":"2026-06-16","kind":"exercise","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":114873,"source":{"system":"sec-edgar","filing":"0001689575-26-000028","document":"form4-06182026_080658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000028/form4-06182026_080658.xml","form_type":"4"}},{"id":741951,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-06-11T20:12:45.000Z","date":"2026-06-09","kind":"exercise","planned":false,"acquired":false,"shares":2462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":4925,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2462},"source":{"system":"sec-edgar","filing":"0001944119-26-000029","document":"form4-06112026_080641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000029/form4-06112026_080641.xml","form_type":"4"}},{"id":741950,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-11T20:12:45.000Z","date":"2026-06-09","kind":"sale","planned":false,"acquired":false,"shares":1266,"price":53.77,"value":68072.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 36,486 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 89,240 shares of Class A Common Stock and options to purchase up to an aggregate of 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":36486,"source":{"system":"sec-edgar","filing":"0001944119-26-000029","document":"form4-06112026_080641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000029/form4-06112026_080641.xml","form_type":"4"}},{"id":741949,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-11T20:12:45.000Z","date":"2026-06-09","kind":"exercise","planned":false,"acquired":true,"shares":2462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":37752,"source":{"system":"sec-edgar","filing":"0001944119-26-000029","document":"form4-06112026_080641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000029/form4-06112026_080641.xml","form_type":"4"}},{"id":741809,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-06-11T20:11:13.000Z","date":"2026-06-09","kind":"exercise","planned":false,"acquired":false,"shares":6546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":13094,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6546},"source":{"system":"sec-edgar","filing":"0001689575-26-000026","document":"form4-06112026_080609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000026/form4-06112026_080609.xml","form_type":"4"}},{"id":741808,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-11T20:11:13.000Z","date":"2026-06-09","kind":"sale","planned":false,"acquired":false,"shares":3639,"price":53.77,"value":195669.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 96,123 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 324,275 shares of Class A Common Stock and options to purchase up to an aggregate of 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":96123,"source":{"system":"sec-edgar","filing":"0001689575-26-000026","document":"form4-06112026_080609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000026/form4-06112026_080609.xml","form_type":"4"}},{"id":741807,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-11T20:11:13.000Z","date":"2026-06-09","kind":"exercise","planned":false,"acquired":true,"shares":6546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":99762,"source":{"system":"sec-edgar","filing":"0001689575-26-000026","document":"form4-06112026_080609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000026/form4-06112026_080609.xml","form_type":"4"}},{"id":746374,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":1,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":2,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":3,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":4,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock, par value $0.0001 per share","published_at":"2026-06-08T21:25:13.000Z","date":"2026-06-05","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":52.8566,"value":2642830.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are owned directly by the Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund (\"Casdin\"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the \"GP\"), and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":3707164,"source":{"system":"sec-edgar","filing":"0000919574-26-003907","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000091957426003907/ownership.xml","form_type":"4"}},{"id":746373,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":1,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":2,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":3,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":4,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock, par value $0.0001 per share","published_at":"2026-06-08T21:25:13.000Z","date":"2026-06-04","kind":"purchase","planned":false,"acquired":true,"shares":150000,"price":56.4449,"value":8466735.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are owned directly by the Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund (\"Casdin\"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the \"GP\"), and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":3657164,"source":{"system":"sec-edgar","filing":"0000919574-26-003907","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000091957426003907/ownership.xml","form_type":"4"}},{"id":752193,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-06-03T20:16:45.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":false,"shares":717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on December 1, 2022. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on December 1, 2022. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":717,"derivative":{"underlying":"Class A Common Stock","underlying_shares":717},"source":{"system":"sec-edgar","filing":"0001944119-26-000027","document":"form4-06032026_080638.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000027/form4-06032026_080638.xml","form_type":"4"}},{"id":752192,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-03T20:16:45.000Z","date":"2026-06-01","kind":"sale","planned":false,"acquired":false,"shares":369,"price":51.74,"value":19092.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 35,290 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate 91,702 shares of Class A Common Stock and options to purchase up to an aggregate 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":35290,"source":{"system":"sec-edgar","filing":"0001944119-26-000027","document":"form4-06032026_080638.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000027/form4-06032026_080638.xml","form_type":"4"}},{"id":752191,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-03T20:16:45.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":true,"shares":717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":35659,"source":{"system":"sec-edgar","filing":"0001944119-26-000027","document":"form4-06032026_080638.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000027/form4-06032026_080638.xml","form_type":"4"}},{"id":770125,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":1,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":2,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":3,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":4,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock, par value $0.0001 per share","published_at":"2026-05-20T23:45:45.000Z","date":"2026-05-20","kind":"purchase","planned":false,"acquired":true,"shares":140000,"price":43.8061,"value":6132854.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $43.6287 to $44.3384. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are owned directly by the Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund (\"Casdin\"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the \"GP\"), and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":3507164,"source":{"system":"sec-edgar","filing":"0000919574-26-003627","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000091957426003627/ownership.xml","form_type":"4"}},{"id":770124,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":1,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":2,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":3,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":4,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock, par value $0.0001 per share","published_at":"2026-05-20T23:45:45.000Z","date":"2026-05-19","kind":"purchase","planned":false,"acquired":true,"shares":185000,"price":42.5964,"value":7880334.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $42.1118 to $42.6898. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are owned directly by the Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund (\"Casdin\"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the \"GP\"), and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":3367164,"source":{"system":"sec-edgar","filing":"0000919574-26-003627","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000091957426003627/ownership.xml","form_type":"4"}},{"id":770123,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":1,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":2,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":3,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":4,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock, par value $0.0001 per share","published_at":"2026-05-20T23:45:45.000Z","date":"2026-05-18","kind":"purchase","planned":false,"acquired":true,"shares":175000,"price":42.5517,"value":7446547.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $42.4573 to $42.9153. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are owned directly by the Casdin Partners Master Fund, L.P. (the \"Master Fund\") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund (\"Casdin\"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the \"GP\"), and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":3182164,"source":{"system":"sec-edgar","filing":"0000919574-26-003627","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000091957426003627/ownership.xml","form_type":"4"}},{"id":777183,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":10282,"kind":"person","name":"Meister Keith A.","position":1,"cik":"0001307631","reported_name":"Meister Keith A.","relationship":{"director":true,"ten_percent_owner":true}},{"id":46919,"kind":"person","name":"Corvex Management LP","position":2,"cik":"0001535472","reported_name":"Corvex Management LP","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2026-05-15T23:07:09.000Z","date":"2026-05-15","kind":"purchase","planned":false,"acquired":true,"shares":18865,"price":39.83,"value":751392.95,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.78 to $40.60."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Investment funds advised by Corvex Management LP (\"Corvex\") are the direct holders of 4,784,570 shares of the Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\") of GeneDX Holdings Corp. (the \"Issuer\") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise."}],"balance_after":4784570,"source":{"system":"sec-edgar","filing":"0001011438-26-000351","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000101143826000351/form4.xml","form_type":"4"}},{"id":777182,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":10282,"kind":"person","name":"Meister Keith A.","position":1,"cik":"0001307631","reported_name":"Meister Keith A.","relationship":{"director":true,"ten_percent_owner":true}},{"id":46919,"kind":"person","name":"Corvex Management LP","position":2,"cik":"0001535472","reported_name":"Corvex Management LP","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2026-05-15T23:07:09.000Z","date":"2026-05-15","kind":"purchase","planned":false,"acquired":true,"shares":27408,"price":38.28,"value":1049178.24,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $37.78 to $38.77."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Investment funds advised by Corvex Management LP (\"Corvex\") are the direct holders of 4,784,570 shares of the Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\") of GeneDX Holdings Corp. (the \"Issuer\") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise."}],"balance_after":4765705,"source":{"system":"sec-edgar","filing":"0001011438-26-000351","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000101143826000351/form4.xml","form_type":"4"}},{"id":777181,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":10282,"kind":"person","name":"Meister Keith A.","position":1,"cik":"0001307631","reported_name":"Meister Keith A.","relationship":{"director":true,"ten_percent_owner":true}},{"id":46919,"kind":"person","name":"Corvex Management LP","position":2,"cik":"0001535472","reported_name":"Corvex Management LP","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2026-05-15T23:07:09.000Z","date":"2026-05-14","kind":"purchase","planned":false,"acquired":true,"shares":51893,"price":39.92,"value":2071568.56,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.79 to $40.00."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Investment funds advised by Corvex Management LP (\"Corvex\") are the direct holders of 4,784,570 shares of the Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\") of GeneDX Holdings Corp. (the \"Issuer\") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise."}],"balance_after":4738297,"source":{"system":"sec-edgar","filing":"0001011438-26-000351","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000101143826000351/form4.xml","form_type":"4"}},{"id":777180,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":10282,"kind":"person","name":"Meister Keith A.","position":1,"cik":"0001307631","reported_name":"Meister Keith A.","relationship":{"director":true,"ten_percent_owner":true}},{"id":46919,"kind":"person","name":"Corvex Management LP","position":2,"cik":"0001535472","reported_name":"Corvex Management LP","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2026-05-15T23:07:09.000Z","date":"2026-05-14","kind":"purchase","planned":false,"acquired":true,"shares":88107,"price":39.08,"value":3443221.56,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $38.79 to $39.77."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Investment funds advised by Corvex Management LP (\"Corvex\") are the direct holders of 4,784,570 shares of the Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\") of GeneDX Holdings Corp. (the \"Issuer\") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise."}],"balance_after":4686404,"source":{"system":"sec-edgar","filing":"0001011438-26-000351","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000101143826000351/form4.xml","form_type":"4"}},{"id":777179,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":10282,"kind":"person","name":"Meister Keith A.","position":1,"cik":"0001307631","reported_name":"Meister Keith A.","relationship":{"director":true,"ten_percent_owner":true}},{"id":46919,"kind":"person","name":"Corvex Management LP","position":2,"cik":"0001535472","reported_name":"Corvex Management LP","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2026-05-15T23:07:09.000Z","date":"2026-05-13","kind":"purchase","planned":false,"acquired":true,"shares":70926,"price":39.45,"value":2798030.7,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.21 to $39.80."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Investment funds advised by Corvex Management LP (\"Corvex\") are the direct holders of 4,784,570 shares of the Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\") of GeneDX Holdings Corp. (the \"Issuer\") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise."}],"balance_after":4598297,"source":{"system":"sec-edgar","filing":"0001011438-26-000351","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000101143826000351/form4.xml","form_type":"4"}},{"id":777178,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":10282,"kind":"person","name":"Meister Keith A.","position":1,"cik":"0001307631","reported_name":"Meister Keith A.","relationship":{"director":true,"ten_percent_owner":true}},{"id":46919,"kind":"person","name":"Corvex Management LP","position":2,"cik":"0001535472","reported_name":"Corvex Management LP","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2026-05-15T23:07:09.000Z","date":"2026-05-13","kind":"purchase","planned":false,"acquired":true,"shares":94074,"price":38.82,"value":3651952.68,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $38.21 to $39.20. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth in footnotes (1), (4), (5), (6), (7) and (8) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Investment funds advised by Corvex Management LP (\"Corvex\") are the direct holders of 4,784,570 shares of the Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\") of GeneDX Holdings Corp. (the \"Issuer\") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise."}],"balance_after":4527371,"source":{"system":"sec-edgar","filing":"0001011438-26-000351","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000101143826000351/form4.xml","form_type":"4"}},{"id":784842,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":10282,"kind":"person","name":"Meister Keith A.","position":1,"cik":"0001307631","reported_name":"Meister Keith A.","relationship":{"director":true,"ten_percent_owner":true}},{"id":46919,"kind":"person","name":"Corvex Management LP","position":2,"cik":"0001535472","reported_name":"Corvex Management LP","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2026-05-12T01:21:58.000Z","date":"2026-05-11","kind":"purchase","planned":false,"acquired":true,"shares":532,"price":40.35,"value":21466.2,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $40.22 to $40.41."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Investment funds advised by Corvex Management LP (\"Corvex\") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\") of GeneDX Holdings Corp. (the \"Issuer\") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise."}],"balance_after":4433297,"source":{"system":"sec-edgar","filing":"0001011438-26-000276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000101143826000276/form4.xml","form_type":"4"}},{"id":784841,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":10282,"kind":"person","name":"Meister Keith A.","position":1,"cik":"0001307631","reported_name":"Meister Keith A.","relationship":{"director":true,"ten_percent_owner":true}},{"id":46919,"kind":"person","name":"Corvex Management LP","position":2,"cik":"0001535472","reported_name":"Corvex Management LP","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2026-05-12T01:21:58.000Z","date":"2026-05-11","kind":"purchase","planned":false,"acquired":true,"shares":252734,"price":39.65,"value":10020903.1,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.22 to $40.21."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Investment funds advised by Corvex Management LP (\"Corvex\") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\") of GeneDX Holdings Corp. (the \"Issuer\") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise."}],"balance_after":4432765,"source":{"system":"sec-edgar","filing":"0001011438-26-000276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000101143826000276/form4.xml","form_type":"4"}},{"id":784840,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":10282,"kind":"person","name":"Meister Keith A.","position":1,"cik":"0001307631","reported_name":"Meister Keith A.","relationship":{"director":true,"ten_percent_owner":true}},{"id":46919,"kind":"person","name":"Corvex Management LP","position":2,"cik":"0001535472","reported_name":"Corvex Management LP","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2026-05-12T01:21:58.000Z","date":"2026-05-11","kind":"purchase","planned":false,"acquired":true,"shares":246734,"price":38.91,"value":9600419.94,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $38.22 to $39.21."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Investment funds advised by Corvex Management LP (\"Corvex\") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\") of GeneDX Holdings Corp. (the \"Issuer\") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise."}],"balance_after":4180031,"source":{"system":"sec-edgar","filing":"0001011438-26-000276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000101143826000276/form4.xml","form_type":"4"}},{"id":784839,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":10282,"kind":"person","name":"Meister Keith A.","position":1,"cik":"0001307631","reported_name":"Meister Keith A.","relationship":{"director":true,"ten_percent_owner":true}},{"id":46919,"kind":"person","name":"Corvex Management LP","position":2,"cik":"0001535472","reported_name":"Corvex Management LP","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2026-05-12T01:21:58.000Z","date":"2026-05-08","kind":"purchase","planned":false,"acquired":true,"shares":73104,"price":41.15,"value":3008229.6,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $40.95 to $41.50."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Investment funds advised by Corvex Management LP (\"Corvex\") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\") of GeneDX Holdings Corp. (the \"Issuer\") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise."}],"balance_after":3933297,"source":{"system":"sec-edgar","filing":"0001011438-26-000276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000101143826000276/form4.xml","form_type":"4"}},{"id":784838,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":10282,"kind":"person","name":"Meister Keith A.","position":1,"cik":"0001307631","reported_name":"Meister Keith A.","relationship":{"director":true,"ten_percent_owner":true}},{"id":46919,"kind":"person","name":"Corvex Management LP","position":2,"cik":"0001535472","reported_name":"Corvex Management LP","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2026-05-12T01:21:58.000Z","date":"2026-05-08","kind":"purchase","planned":false,"acquired":true,"shares":79144,"price":40.67,"value":3218786.48,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.95 to $40.94."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Investment funds advised by Corvex Management LP (\"Corvex\") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\") of GeneDX Holdings Corp. (the \"Issuer\") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise."}],"balance_after":3860193,"source":{"system":"sec-edgar","filing":"0001011438-26-000276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000101143826000276/form4.xml","form_type":"4"}},{"id":784837,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":10282,"kind":"person","name":"Meister Keith A.","position":1,"cik":"0001307631","reported_name":"Meister Keith A.","relationship":{"director":true,"ten_percent_owner":true}},{"id":46919,"kind":"person","name":"Corvex Management LP","position":2,"cik":"0001535472","reported_name":"Corvex Management LP","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2026-05-12T01:21:58.000Z","date":"2026-05-08","kind":"purchase","planned":false,"acquired":true,"shares":3396,"price":38.7,"value":131425.2,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $38.59 to $38.94."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Investment funds advised by Corvex Management LP (\"Corvex\") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\") of GeneDX Holdings Corp. (the \"Issuer\") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise."}],"balance_after":3781049,"source":{"system":"sec-edgar","filing":"0001011438-26-000276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000101143826000276/form4.xml","form_type":"4"}},{"id":784836,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":10282,"kind":"person","name":"Meister Keith A.","position":1,"cik":"0001307631","reported_name":"Meister Keith A.","relationship":{"director":true,"ten_percent_owner":true}},{"id":46919,"kind":"person","name":"Corvex Management LP","position":2,"cik":"0001535472","reported_name":"Corvex Management LP","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2026-05-12T01:21:58.000Z","date":"2026-05-08","kind":"purchase","planned":false,"acquired":true,"shares":15745,"price":38,"value":598310.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $37.59 to $38.58."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Investment funds advised by Corvex Management LP (\"Corvex\") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\") of GeneDX Holdings Corp. (the \"Issuer\") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise."}],"balance_after":3777653,"source":{"system":"sec-edgar","filing":"0001011438-26-000276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000101143826000276/form4.xml","form_type":"4"}},{"id":784835,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":10282,"kind":"person","name":"Meister Keith A.","position":1,"cik":"0001307631","reported_name":"Meister Keith A.","relationship":{"director":true,"ten_percent_owner":true}},{"id":46919,"kind":"person","name":"Corvex Management LP","position":2,"cik":"0001535472","reported_name":"Corvex Management LP","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2026-05-12T01:21:58.000Z","date":"2026-05-07","kind":"purchase","planned":false,"acquired":true,"shares":56630,"price":40.46,"value":2291249.8,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $40.05 to $40.66."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Investment funds advised by Corvex Management LP (\"Corvex\") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\") of GeneDX Holdings Corp. (the \"Issuer\") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise."}],"balance_after":3761908,"source":{"system":"sec-edgar","filing":"0001011438-26-000276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000101143826000276/form4.xml","form_type":"4"}},{"id":784834,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":10282,"kind":"person","name":"Meister Keith A.","position":1,"cik":"0001307631","reported_name":"Meister Keith A.","relationship":{"director":true,"ten_percent_owner":true}},{"id":46919,"kind":"person","name":"Corvex Management LP","position":2,"cik":"0001535472","reported_name":"Corvex Management LP","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2026-05-12T01:21:58.000Z","date":"2026-05-07","kind":"purchase","planned":false,"acquired":true,"shares":94356,"price":39.39,"value":3716682.84,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $39.05 to $40.04."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Investment funds advised by Corvex Management LP (\"Corvex\") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\") of GeneDX Holdings Corp. (the \"Issuer\") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise."}],"balance_after":3705278,"source":{"system":"sec-edgar","filing":"0001011438-26-000276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000101143826000276/form4.xml","form_type":"4"}},{"id":784833,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":10282,"kind":"person","name":"Meister Keith A.","position":1,"cik":"0001307631","reported_name":"Meister Keith A.","relationship":{"director":true,"ten_percent_owner":true}},{"id":46919,"kind":"person","name":"Corvex Management LP","position":2,"cik":"0001535472","reported_name":"Corvex Management LP","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2026-05-12T01:21:58.000Z","date":"2026-05-07","kind":"purchase","planned":false,"acquired":true,"shares":116412,"price":38.46,"value":4477205.52,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $38.05 to $39.04."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Investment funds advised by Corvex Management LP (\"Corvex\") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\") of GeneDX Holdings Corp. (the \"Issuer\") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise."}],"balance_after":3610922,"source":{"system":"sec-edgar","filing":"0001011438-26-000276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000101143826000276/form4.xml","form_type":"4"}},{"id":784832,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":10282,"kind":"person","name":"Meister Keith A.","position":1,"cik":"0001307631","reported_name":"Meister Keith A.","relationship":{"director":true,"ten_percent_owner":true}},{"id":46919,"kind":"person","name":"Corvex Management LP","position":2,"cik":"0001535472","reported_name":"Corvex Management LP","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2026-05-12T01:21:58.000Z","date":"2026-05-07","kind":"purchase","planned":false,"acquired":true,"shares":123393,"price":37.6,"value":4639576.8,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $37.05 to $38.04."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Investment funds advised by Corvex Management LP (\"Corvex\") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\") of GeneDX Holdings Corp. (the \"Issuer\") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise."}],"balance_after":3494510,"source":{"system":"sec-edgar","filing":"0001011438-26-000276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000101143826000276/form4.xml","form_type":"4"}},{"id":784831,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":10282,"kind":"person","name":"Meister Keith A.","position":1,"cik":"0001307631","reported_name":"Meister Keith A.","relationship":{"director":true,"ten_percent_owner":true}},{"id":46919,"kind":"person","name":"Corvex Management LP","position":2,"cik":"0001535472","reported_name":"Corvex Management LP","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2026-05-12T01:21:58.000Z","date":"2026-05-07","kind":"purchase","planned":false,"acquired":true,"shares":14786,"price":36.33,"value":537175.38,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $35.97 to $36.84."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Investment funds advised by Corvex Management LP (\"Corvex\") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\") of GeneDX Holdings Corp. (the \"Issuer\") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise."}],"balance_after":3371117,"source":{"system":"sec-edgar","filing":"0001011438-26-000276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000101143826000276/form4.xml","form_type":"4"}},{"id":784830,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":10282,"kind":"person","name":"Meister Keith A.","position":1,"cik":"0001307631","reported_name":"Meister Keith A.","relationship":{"director":true,"ten_percent_owner":true}},{"id":46919,"kind":"person","name":"Corvex Management LP","position":2,"cik":"0001535472","reported_name":"Corvex Management LP","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Class A Common Stock","published_at":"2026-05-12T01:21:58.000Z","date":"2026-05-07","kind":"purchase","planned":false,"acquired":true,"shares":128181,"price":35.46,"value":4545298.26,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $34.97 to $35.94. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth in footnotes (1), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14) and (15) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Investment funds advised by Corvex Management LP (\"Corvex\") are the direct holders of 4,433,297 shares of the Class A Common Stock, par value $0.0001 per share (\"Class A Common Stock\") of GeneDX Holdings Corp. (the \"Issuer\") reported herein. Mr. Meister may be deemed to indirectly beneficially own these shares by virtue of Mr. Meister's control of the general partner of Corvex."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"For the purposes of this filing, each of Corvex and Mr. Meister disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. This filing shall not be deemed an admission that Corvex or Mr. Meister is the beneficial owner of any of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise."}],"balance_after":3356331,"source":{"system":"sec-edgar","filing":"0001011438-26-000276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000101143826000276/form4.xml","form_type":"4"}},{"id":784825,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":1,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":2,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":3,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":4,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Cash Settled Swap","published_at":"2026-05-12T00:43:39.000Z","date":"2026-05-11","kind":"purchase","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Master Fund has entered into certain cash-settled swap agreements (the \"Swap Agreements\"), which represent economic exposure to an aggregate of 50,000 notional shares of the Issuer's Class A Common Stock, at a price of $39.6602 per share. The Swap Agreements provide the Master Fund with economic results that are comparable to the economic results of ownership but do not provide it with the power to vote or direct the voting or dispose of or direct the disposition of the securities that are referenced by the Swap Agreements."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Master Fund has entered into certain cash-settled swap agreements (the \"Swap Agreements\"), which represent economic exposure to an aggregate of 50,000 notional shares of the Issuer's Class A Common Stock, at a price of $39.6602 per share. The Swap Agreements provide the Master Fund with economic results that are comparable to the economic results of ownership but do not provide it with the power to vote or direct the voting or dispose of or direct the disposition of the securities that are referenced by the Swap Agreements."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Master Fund has entered into certain cash-settled swap agreements (the \"Swap Agreements\"), which represent economic exposure to an aggregate of 50,000 notional shares of the Issuer's Class A Common Stock, at a price of $39.6602 per share. The Swap Agreements provide the Master Fund with economic results that are comparable to the economic results of ownership but do not provide it with the power to vote or direct the voting or dispose of or direct the disposition of the securities that are referenced by the Swap Agreements."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Master Fund has entered into certain cash-settled swap agreements (the \"Swap Agreements\"), which represent economic exposure to an aggregate of 50,000 notional shares of the Issuer's Class A Common Stock, at a price of $39.6602 per share. The Swap Agreements provide the Master Fund with economic results that are comparable to the economic results of ownership but do not provide it with the power to vote or direct the voting or dispose of or direct the disposition of the securities that are referenced by the Swap Agreements."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Swap Agreements are owned directly by the Master Fund and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund (\"Casdin\"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the \"GP\"), and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":850000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000919574-26-002845","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000091957426002845/ownership.xml","form_type":"4"}},{"id":784824,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":1,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":2,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":3,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":4,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Cash Settled Swap","published_at":"2026-05-12T00:43:39.000Z","date":"2026-05-08","kind":"purchase","planned":false,"acquired":true,"shares":300000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Master Fund has entered into certain cash-settled swap agreements (the \"Swap Agreements\"), which represent economic exposure to an aggregate of 300,000 notional shares of the Issuer's Class A Common Stock, at a price of $41.0261 per share. The Swap Agreements provide the Master Fund with economic results that are comparable to the economic results of ownership but do not provide it with the power to vote or direct the voting or dispose of or direct the disposition of the securities that are referenced by the Swap Agreements."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Master Fund has entered into certain cash-settled swap agreements (the \"Swap Agreements\"), which represent economic exposure to an aggregate of 300,000 notional shares of the Issuer's Class A Common Stock, at a price of $41.0261 per share. The Swap Agreements provide the Master Fund with economic results that are comparable to the economic results of ownership but do not provide it with the power to vote or direct the voting or dispose of or direct the disposition of the securities that are referenced by the Swap Agreements."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Master Fund has entered into certain cash-settled swap agreements (the \"Swap Agreements\"), which represent economic exposure to an aggregate of 300,000 notional shares of the Issuer's Class A Common Stock, at a price of $41.0261 per share. The Swap Agreements provide the Master Fund with economic results that are comparable to the economic results of ownership but do not provide it with the power to vote or direct the voting or dispose of or direct the disposition of the securities that are referenced by the Swap Agreements."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Master Fund has entered into certain cash-settled swap agreements (the \"Swap Agreements\"), which represent economic exposure to an aggregate of 300,000 notional shares of the Issuer's Class A Common Stock, at a price of $41.0261 per share. The Swap Agreements provide the Master Fund with economic results that are comparable to the economic results of ownership but do not provide it with the power to vote or direct the voting or dispose of or direct the disposition of the securities that are referenced by the Swap Agreements."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Swap Agreements are owned directly by the Master Fund and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund (\"Casdin\"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the \"GP\"), and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":800000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000919574-26-002845","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000091957426002845/ownership.xml","form_type":"4"}},{"id":784823,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":40531,"kind":"person","name":"Casdin Capital, LLC","position":1,"cik":"0001534261","reported_name":"Casdin Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":36006,"kind":"person","name":"Casdin Eli","position":2,"cik":"0001534264","reported_name":"Casdin Eli","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40532,"kind":"person","name":"Casdin Partners Master Fund, L.P.","position":3,"cik":"0001534265","reported_name":"Casdin Partners Master Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":40533,"kind":"person","name":"Casdin Partners GP, LLC","position":4,"cik":"0001534260","reported_name":"Casdin Partners GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Cash Settled Swap","published_at":"2026-05-12T00:43:39.000Z","date":"2026-05-07","kind":"purchase","planned":false,"acquired":true,"shares":500000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Casdin Partners Master Fund, L.P. (the \"Master Fund\") has entered into certain cash-settled swap agreements (the \"Swap Agreements\"), which represent economic exposure to an aggregate of 500,000 notional shares of the Issuer's Class A Common Stock, at a price of $38.1543 per share. The Swap Agreements provide the Master Fund with economic results that are comparable to the economic results of ownership but do not provide it with the power to vote or direct the voting or dispose of or direct the disposition of the securities that are referenced by the Swap Agreements."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Casdin Partners Master Fund, L.P. (the \"Master Fund\") has entered into certain cash-settled swap agreements (the \"Swap Agreements\"), which represent economic exposure to an aggregate of 500,000 notional shares of the Issuer's Class A Common Stock, at a price of $38.1543 per share. The Swap Agreements provide the Master Fund with economic results that are comparable to the economic results of ownership but do not provide it with the power to vote or direct the voting or dispose of or direct the disposition of the securities that are referenced by the Swap Agreements."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Casdin Partners Master Fund, L.P. (the \"Master Fund\") has entered into certain cash-settled swap agreements (the \"Swap Agreements\"), which represent economic exposure to an aggregate of 500,000 notional shares of the Issuer's Class A Common Stock, at a price of $38.1543 per share. The Swap Agreements provide the Master Fund with economic results that are comparable to the economic results of ownership but do not provide it with the power to vote or direct the voting or dispose of or direct the disposition of the securities that are referenced by the Swap Agreements."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Casdin Partners Master Fund, L.P. (the \"Master Fund\") has entered into certain cash-settled swap agreements (the \"Swap Agreements\"), which represent economic exposure to an aggregate of 500,000 notional shares of the Issuer's Class A Common Stock, at a price of $38.1543 per share. The Swap Agreements provide the Master Fund with economic results that are comparable to the economic results of ownership but do not provide it with the power to vote or direct the voting or dispose of or direct the disposition of the securities that are referenced by the Swap Agreements."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Swap Agreements are owned directly by the Master Fund and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund (\"Casdin\"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the \"GP\"), and (iii) Eli Casdin, the managing member of Casdin and the GP."}],"balance_after":500000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000919574-26-002845","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000091957426002845/ownership.xml","form_type":"4"}},{"id":795793,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-05-01T20:28:12.000Z","date":"2026-04-29","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the total award vested on each of April 29, 2023 and April 29, 2024, and an additional 6.25% of the total award vested or vests thereafter on each quarterly anniversary, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the last tranche vesting on April 29, 2026.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"25% of the total award vested on each of April 29, 2023 and April 29, 2024, and an additional 6.25% of the total award vested or vests thereafter on each quarterly anniversary, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the last tranche vesting on April 29, 2026.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0001689575-26-000024","document":"form4-05012026_080508.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000024/form4-05012026_080508.xml","form_type":"4"}},{"id":795792,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-05-01T20:28:12.000Z","date":"2026-04-29","kind":"sale","planned":false,"acquired":false,"shares":18,"price":64.12,"value":1154.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 93,216 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 330,821 shares of Class A Common Stock and options to purchase up to an aggregate of 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":93216,"source":{"system":"sec-edgar","filing":"0001689575-26-000024","document":"form4-05012026_080508.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000024/form4-05012026_080508.xml","form_type":"4"}},{"id":795791,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-05-01T20:28:12.000Z","date":"2026-04-29","kind":"sale","planned":false,"acquired":false,"shares":2154,"price":65.2,"value":140440.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":93234,"source":{"system":"sec-edgar","filing":"0001689575-26-000024","document":"form4-05012026_080508.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000024/form4-05012026_080508.xml","form_type":"4"}},{"id":795790,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-05-01T20:28:12.000Z","date":"2026-04-29","kind":"exercise","planned":false,"acquired":true,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":95388,"source":{"system":"sec-edgar","filing":"0001689575-26-000024","document":"form4-05012026_080508.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000024/form4-05012026_080508.xml","form_type":"4"}},{"id":795853,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-05-01T20:24:33.000Z","date":"2026-04-29","kind":"exercise","planned":false,"acquired":false,"shares":754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the total award vested on each of April 29, 2023 and April 29, 2024, and an additional 6.25% of the total award vested or vests thereafter on each quarterly anniversary, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the last tranche vesting on April 29, 2026.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"25% of the total award vested on each of April 29, 2023 and April 29, 2024, and an additional 6.25% of the total award vested or vests thereafter on each quarterly anniversary, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the last tranche vesting on April 29, 2026.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":754},"source":{"system":"sec-edgar","filing":"0001944119-26-000024","document":"form4-05012026_080528.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000024/form4-05012026_080528.xml","form_type":"4"}},{"id":795852,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-05-01T20:24:33.000Z","date":"2026-04-29","kind":"sale","planned":false,"acquired":false,"shares":392,"price":65.1926,"value":25555.4992,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.4739 to $65.20 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 34,942 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 92,419 shares of Class A Common Stock and options to purchase up to an aggregate of 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":34942,"source":{"system":"sec-edgar","filing":"0001944119-26-000024","document":"form4-05012026_080528.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000024/form4-05012026_080528.xml","form_type":"4"}},{"id":795851,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-05-01T20:24:33.000Z","date":"2026-04-29","kind":"exercise","planned":false,"acquired":true,"shares":754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":35334,"source":{"system":"sec-edgar","filing":"0001944119-26-000024","document":"form4-05012026_080528.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000024/form4-05012026_080528.xml","form_type":"4"}},{"id":825383,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-03-30T21:38:19.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":false,"shares":16250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"25% of the total award vested or vests annually, with the first tranche vested on March 26, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"25% of the total award vested or vests annually, with the first tranche vested on March 26, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":32500,"derivative":{"underlying":"Class A Common Stock","underlying_shares":16250},"source":{"system":"sec-edgar","filing":"0001944119-26-000021","document":"form4-03302026_090356.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000021/form4-03302026_090356.xml","form_type":"4"}},{"id":825382,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-30T21:38:19.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":1857,"price":65.2143,"value":121102.9551,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.61 per share, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 34,580 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 93,173 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 25,906 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":34580,"source":{"system":"sec-edgar","filing":"0001944119-26-000021","document":"form4-03302026_090356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000021/form4-03302026_090356.xml","form_type":"4"}},{"id":825381,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":1635,"kind":"person","name":"Feeley Kevin","position":1,"cik":"0001944119","reported_name":"Feeley Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-30T21:38:19.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":995,"price":64.5993,"value":64276.3035,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.99 to $64.96 per share, inclusive."}],"balance_after":36437,"source":{"system":"sec-edgar","filing":"0001944119-26-000021","document":"form4-03302026_090356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1944119/000194411926000021/form4-03302026_090356.xml","form_type":"4"}}],"next_cursor":"2026-03-30T21:38:19.000000Z,825381"}